Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Drummond MB, Dasenbrook EC, Pitz MW, Murphy DJ, Fan E.

JAMA. 2008 Nov 26;300(20):2407-16. doi: 10.1001/jama.2008.717. Review. Erratum in: JAMA. 2009 Mar 11;301(10):1024.

2.

Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease.

Kew KM, Seniukovich A.

Cochrane Database Syst Rev. 2014 Mar 10;(3):CD010115. doi: 10.1002/14651858.CD010115.pub2. Review.

PMID:
24615270
3.

Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.

Sobieraj DM, White CM, Coleman CI.

Clin Ther. 2008 Aug;30(8):1416-25. doi: 10.1016/j.clinthera.2008.08.004.

PMID:
18803985
4.

Inhaled corticosteroids for stable chronic obstructive pulmonary disease.

Yang IA, Clarke MS, Sim EH, Fong KM.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD002991. doi: 10.1002/14651858.CD002991.pub3. Review.

PMID:
22786484
5.

Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Nannini LJ, Lasserson TJ, Poole P.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD006829. doi: 10.1002/14651858.CD006829.pub2. Review.

6.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Spencer S, Karner C, Cates CJ, Evans DJ.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD007033. doi: 10.1002/14651858.CD007033.pub3. Review.

PMID:
22161409
7.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Spencer S, Evans DJ, Karner C, Cates CJ.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007033. doi: 10.1002/14651858.CD007033.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(12):CD007033.

PMID:
21975759
8.

Beclometasone for chronic obstructive pulmonary disease.

De Coster DA, Jones M, Thakrar N.

Cochrane Database Syst Rev. 2013 Oct 9;(10):CD009769. doi: 10.1002/14651858.CD009769.pub2. Review.

PMID:
24105424
9.

Combination inhaled steroid and long-acting beta₂-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease.

Rojas-Reyes MX, García Morales OM, Dennis RJ, Karner C.

Cochrane Database Syst Rev. 2016 Jun 6;(6):CD008532. doi: 10.1002/14651858.CD008532.pub3. Review.

PMID:
27271056
10.

Combined corticosteroid and long-acting beta₂-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease.

Nannini LJ, Poole P, Milan SJ, Holmes R, Normansell R.

Cochrane Database Syst Rev. 2013 Nov 10;(11):CD003794. doi: 10.1002/14651858.CD003794.pub4. Review.

11.

Inhaled corticosteroids for stable chronic obstructive pulmonary disease.

Yang IA, Fong KM, Sim EH, Black PN, Lasserson TJ.

Cochrane Database Syst Rev. 2007 Apr 18;(2):CD002991. Review. Update in: Cochrane Database Syst Rev. 2012;7:CD002991.

PMID:
17443520
12.

Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis.

Kew KM, Dias S, Cates CJ.

Cochrane Database Syst Rev. 2014 Mar 26;(3):CD010844. doi: 10.1002/14651858.CD010844.pub2. Review.

PMID:
24671923
13.

Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease.

Nannini LJ, Poole P, Milan SJ, Kesterton A.

Cochrane Database Syst Rev. 2013 Aug 30;(8):CD006826. doi: 10.1002/14651858.CD006826.pub2. Review.

PMID:
23990350
14.

Managing the safety of inhaled corticosteroids in COPD and the risk of pneumonia.

Liapikou A, Toumbis M, Torres A.

Expert Opin Drug Saf. 2015 Aug;14(8):1237-47. doi: 10.1517/14740338.2015.1057494. Epub 2015 Jun 25. Review.

PMID:
26113207
15.

Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.

Chong J, Karner C, Poole P.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD009157. doi: 10.1002/14651858.CD009157.pub2. Review.

PMID:
22972134
16.

Early use of inhaled corticosteroids in the emergency department treatment of acute asthma.

Edmonds ML, Milan SJ, Camargo CA Jr, Pollack CV, Rowe BH.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD002308. doi: 10.1002/14651858.CD002308.pub2. Review.

PMID:
23235589
17.

Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.

Greenstone IR, Ni Chroinin MN, Masse V, Danish A, Magdalinos H, Zhang X, Ducharme FM.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005533. Review. Update in: Cochrane Database Syst Rev. 2010;(4):CD005533.

PMID:
16235409
18.

Inhaled corticosteroids in children with persistent asthma: effects on growth.

Zhang L, Prietsch SO, Ducharme FM.

Evid Based Child Health. 2014 Dec;9(4):829-930. doi: 10.1002/ebch.1988.

PMID:
25504972
19.

Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.

Chauhan BF, Chartrand C, Ni Chroinin M, Milan SJ, Ducharme FM.

Cochrane Database Syst Rev. 2015 Nov 24;(11):CD007949. doi: 10.1002/14651858.CD007949.pub2. Review.

PMID:
26594816
20.

Inhaled steroids for acute asthma following emergency department discharge.

Edmonds ML, Milan SJ, Brenner BE, Camargo CA Jr, Rowe BH.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD002316. doi: 10.1002/14651858.CD002316.pub2. Review.

PMID:
23235590

Supplemental Content

Support Center